Trials / Completed
CompletedNCT02924324
Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients
RePPAIR -Reducing Procedural Pain and Improving Recovery of Quality of Life in Pediatric Neuroblastoma Patients Undergoing Bone Marrow Procedures: A Prospective Randomized Cross-over Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 3 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to identify whether or not the addition of a numbing medicine that is injected directly into the site of the bone marrow procedure can reduce pain and the use of opioid pain medication after bone marrow procedures. The addition of this medicine, called ropivacaine, is the experimental part of this study. This is the first time ropivacaine will be directly injected into the bone marrow site at MSKCC Pediatrics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | propofol | |
| DRUG | ropivacaine | |
| BEHAVIORAL | Wong-Baker FACES® Pain Rating Scale | Nurses will record patient-reported pain scores. |
| BEHAVIORAL | Post-procedural quality of life (QOL) |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2019-11-01
- Completion
- 2019-11-01
- First posted
- 2016-10-05
- Last updated
- 2022-11-08
- Results posted
- 2022-04-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02924324. Inclusion in this directory is not an endorsement.